LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR)
CUSIP: 514766104
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 37,508,353
- Total 13F shares
- 23,042,098
- Share change
- +4,075,802
- Total reported value
- $171,205,266
- Put/Call ratio
- 36%
- Price per share
- $7.43
- Number of holders
- 74
- Value change
- +$31,378,307
- Number of buys
- 39
- Number of sells
- 37
Quarterly Holders Quick Answers
What is CUSIP 514766104?
CUSIP 514766104 identifies LFCR - LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 514766104:
Top shareholders of LFCR - LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WYNNEFIELD CAPITAL INC |
13F
|
Company |
13%
|
4,918,979
|
$24,250,566 | — | 30 Sep 2024 | |
| 22NW, LP |
13F
|
Company |
4.7%
|
1,755,161
|
$23,652,944 | — | 30 Sep 2024 | |
| Greenhaven Road Investment Management, L.P. |
13D/G
13F
|
Company |
9.8%
|
3,616,146
|
$22,998,689 | +$7,944,848 | 31 Dec 2024 | |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,703,216
|
$19,283,185 | — | 03 Oct 2024 | |
| Legion Partners Asset Management, LLC |
13F
|
Company |
7.9%
|
2,968,409
|
$14,634,256 | — | 30 Sep 2024 | |
| David Capital Partners, LLC |
13D/G
|
— |
4.9%
|
1,803,000
|
$11,467,080 | $0 | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
4%
|
1,512,946
|
$7,458,824 | — | 30 Sep 2024 | |
| 325 CAPITAL LLC |
13F
|
Company |
3.7%
|
1,369,785
|
$6,753,040 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
1,315,216
|
$6,484,014 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.1%
|
776,690
|
$3,829,083 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
597,685
|
$2,947,546 | — | 30 Sep 2024 | |
| James G. Hall |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
276,096
|
$2,876,920 | — | 01 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.89%
|
334,360
|
$1,648,395 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.84%
|
315,719
|
$1,556,495 | — | 30 Sep 2024 | |
| DCF Advisers, LLC |
13F
|
Company |
0.77%
|
288,478
|
$1,422,197 | — | 30 Sep 2024 | |
| John D. Morberg |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
125,617
|
$1,308,929 | — | 18 Jan 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.54%
|
200,700
|
$989,452 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.52%
|
193,479
|
$953,851 | — | 30 Sep 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
187,146
|
$922,630 | — | 30 Sep 2024 | |
| Craig A. Barbarosh |
3/4/5
|
Director |
—
class O/S missing
|
88,073
|
$917,721 | — | 08 Jul 2024 | |
| Jeffrey L. Edwards |
3/4/5
|
Director |
—
class O/S missing
|
79,667
|
$830,130 | — | 08 Jul 2024 | |
| Albert D. Bolles |
3/4/5
|
Chief Executive Officer |
—
class O/S missing
|
72,883
|
$759,441 | — | 23 May 2022 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.4%
|
151,700
|
$747,881 | — | 30 Sep 2024 | |
| Raymond H. Diradoorian |
3/4/5
|
Director |
—
class O/S missing
|
69,978
|
$729,171 | — | 08 Jul 2024 | |
| 272 Capital LP |
13F
|
Company |
0.38%
|
143,480
|
$707,356 | — | 30 Sep 2024 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.34%
|
127,904
|
$630,567 | — | 30 Sep 2024 | |
| Tonia L. Pankopf |
3/4/5
|
Director |
—
class O/S missing
|
59,599
|
$621,022 | — | 04 Jun 2022 | |
| Nathaniel Calloway |
3/4/5
|
Director |
—
class O/S missing
|
58,069
|
$605,079 | — | 08 Jul 2024 | |
| Catherine A. Sohn |
3/4/5
|
Director |
—
class O/S missing
|
54,069
|
$563,399 | — | 04 Jun 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.25%
|
94,376
|
$465,274 | — | 30 Sep 2024 | |
| GAMCO INVESTORS, INC. ET AL |
13F
|
Company |
0.23%
|
87,500
|
$431,375 | — | 30 Sep 2024 | |
| Deborah D. Carosella |
3/4/5
|
Director |
—
class O/S missing
|
36,588
|
$381,247 | — | 04 Jun 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.21%
|
76,900
|
$379,117 | — | 30 Sep 2024 | |
| Diametric Capital, LP |
13F
|
Company |
0.2%
|
75,525
|
$372,338 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
60,505
|
$298,290 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.16%
|
58,914
|
$290,446 | — | 30 Sep 2024 | |
| Andrew Kenneth William Powell |
3/4/5
|
Director |
—
class O/S missing
|
27,477
|
$286,310 | — | 04 Jun 2022 | |
| WITTENBERG INVESTMENT MANAGEMENT, INC. |
13F
|
Company |
0.15%
|
57,896
|
$285,427 | — | 30 Sep 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.15%
|
54,399
|
$268,187 | — | 30 Sep 2024 | |
| Timothy P. Burgess |
3/4/5
|
Senior VP of Supply Chain |
—
mixed-class rows
|
30,000
mixed-class rows
|
$239,704 | — | 27 Jul 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.12%
|
46,882
|
$231,128 | — | 30 Sep 2024 | |
| Diversified Trust Co |
13F
|
Company |
0.12%
|
46,121
|
$227,376 | — | 30 Sep 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.11%
|
42,074
|
$207,425 | — | 30 Sep 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.11%
|
41,529
|
$205,000 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.1%
|
36,246
|
$178,693 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.1%
|
36,091
|
$177,929 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
29,944
|
$147,624 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.08%
|
28,837
|
$142,166 | — | 30 Sep 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.07%
|
27,774
|
$136,926 | — | 30 Sep 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
27,504
|
$135,595 | — | 30 Sep 2024 |
Institutional Holders of LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR) as of Q4 2024
As of 31 Dec 2024,
LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,042,098 shares.
The largest 10 holders included
WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., 325 CAPITAL LLC, BlackRock, Inc., VANGUARD GROUP INC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, Invesco Ltd., and DCF Advisers, LLC.
This page lists
75
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
80
Q4 2024 holders
74
Holder diff
-6
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.